Richard J. Knight, MD

Professor of Surgery, Institute for Academic Medicine
Houston Methodist
Weill Cornell Medical College


Education & Training

Clinical Fellowship , University of Texas Medical School at Houston
Residency , Mount Sinai Medical Center
Internship , Mount Sinai Medical Center
MD , Tulane University
Publications

Belatacept conversion in an HIV-positive kidney transplant recipient following anti-thymocyte globulin induction
Kuten, SA, Patel, SJ, Baru, A, Gaber, AO, Crutchley, RD, Ramanathan, V & Knight, RJ 2017, Transplant Infectious Disease, vol 19, no. 5, e12748. DOI: 10.1111/tid.12748

The detrimental impact of persistent vs an isolated occurrence of de novo donor-specific antibodies on intermediate-term renal transplant outcomes
Loucks-DeVos, JM, Eagar, TN, Gaber, AO, Patel, SJ, Teeter, LD, Graviss, EA & Knight, RJ 2017, Clinical Transplantation, vol 31, no. 8. DOI: 10.1111/ctr.13025

Early clearance vs persistence of de novo donor-specific antibodies following lung transplantation
Islam, AK, Sinha, N, DeVos, JM, Kaleekal, TS, Jyothula, SS, Teeter, LD, Nguyen, DTM, Eagar, TN, Moore, LW, Puppala, M, Wong, STC, Knight, RJ, Frost, AE, Graviss, EA & Osama Gaber, A 2017, Clinical Transplantation. DOI: 10.1111/ctr.13028

Incidence and Factors Associated with De Novo DSA After BK Viremia in Renal Transplant Recipients
Patel, SJ, Kuten, SA, Knight, RJ, Graviss, EA, Nguyen, DTM & Gaber, AO 2017, . in Clinical Transplants 2016. Terasaki Research Institute, Los Angeles, California, pp. 103-109.

Neurogenic Orthostatic Hypotension: An Iatrogenic Complication of Successful Pancreas Transplantation?
Kuten, SA, Simpson, EP, Gaber, AO, Nguyen, DTM, Graviss, EA, Patel, S & Knight, RJ 2017, .

The Incidence and Outcomes of Fever of Unknown Origin After Pancreas Transplantation
Klasek, R, Kuten, SA, Patel, S, Nguyen, DT, Graviss, EA, Gaber, AO & Knight, RJ 2017, American Journal of Transplantation, vol 17, no. suppl 3, 17 (suppl 3).

The detrimental impact of persistent vs an isolated occurrence of de novo donor-specific antibodies on intermediate-term renal transplant outcomes
Loucks-DeVos, JM, Eagar, TN, Gaber, AO, Patel, SJ, Teeter, LD, Graviss, EA & Knight, RJ 2017, Clinical Transplantation, vol 31, no. 8. DOI: 10.1111/ctr.13025

Combination Drug Products for HIV—A Word of Caution for the Transplant Clinician
Patel, SJ, Kuten, SA, Musick, WL, Gaber, AO, Monsour, HP & Knight, R 2016, American Journal of Transplantation, vol 16, no. 8, pp. 2479-2482. DOI: 10.1111/ajt.13826

Intermediate-Term Outcomes of Dual Adult versus Single-Kidney Transplantation: Evolution of a Surgical Technique
Islam, AK, Knight, RJ, Mayer, WA, Hollander, AB, Patel, S, Teeter, LD, Graviss, EA, Saharia, A, Podder, H, Asham, EH & Gaber, AO 2016, The Journal of Heart Transplantation, vol 2016, pp. 2586761. DOI: 10.1155/2016/2586761

Disparate rates of acute rejection and donor-specific antibodies among high-immunologic risk renal transplant subgroups receiving antithymocyte globulin induction
Patel, SJ, Suki, WN, Loucks-DeVos, J, Graviss, EA, Nguyen, DT, Knight, RJ, Kuten, SA, Moore, LW, Teeter, LD, Gaber, LW & Gaber, AO 2016, Transplant International, vol 29, no. 8, pp. 897-908. DOI: 10.1111/tri.12791

Excessive Weight Gain After Pancreas Transplant: Transitioning from Type 1 to Type 2 Diabetes?
Islam, AK, Lawless, A, Teeter, LD, Graviss, E, Victor, III, DW, Sadhu, A, Patel, SJ, Gaber, AO & Knight, R 2015, American Journal of Transplantation, vol 2015, no. 15 (suppl3), 2015; 15.

Barriers to preemptive renal transplantation: a single center questionnaire study
Knight, RJ, Teeter, LD, Graviss, EA, Patel, SJ, DeVos, JM, Moore, LW & Gaber, AO 2015, Transplantation, vol 99, no. 3, pp. 576-579. DOI: 10.1097/TP.0000000000000357

Observations on the use of cidofovir for BK virus infection in renal transplantation
Kuten, SA, Patel, SJ, Knight, RJ, Gaber, LW, Devos, JM & Gaber, AO 2015, Transplant Infectious Disease, vol 16, no. 6, pp. 975-983. DOI: 10.1111/tid.12313

Intermediate-term graft loss after renal transplantation is associated with both donor-specific antibody and acute rejection
Devos, JM, Gaber, AO, Teeter, LD, Graviss, EA, Patel, SJ, Land, GA, Moore, LW & Knight, RJ 2014, Transplantation, vol 97, no. 5, pp. 534-540. DOI: 10.1097/01.TP.0000438196.30790.66

Resolution of Mild Ganciclovir-Resistant Cytomegalovirus Disease with Reduced-Dose Cidofovir and CMV-Hyperimmune Globulin
Patel, SJ, Kuten, SA, Knight, RJ, Hong, DM & Gaber, AO 2014, Journal of Heart Transplantation, vol 2014, pp. 342319. DOI: 10.1155/2014/342319

A surgeons' guide to renal transplant immunopathology, immunology, and immunosuppression
Gaber, LW , Knight, RJ & Patel, SJ 2013, Surgical Clinics of North America, vol 93, no. 6, pp. 1293-1307. DOI: 10.1016/j.suc.2013.09.002

Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy
Knight, RJ , Gaber, LW, Patel, SJ, Devos, JM, Moore, LW & Gaber, AO 2013, Transplantation, vol 96, no. 7. DOI: 10.1097/TP.0b013e3182a68935

Cross-sectional and case-control analyses of the association of kidney function staging with adverse postoperative outcomes in general and vascular surgery
Gaber, AO , Moore, LW, Aloia, TA, Suki, WN, Jones, SL, Graviss, EA, Knight, RJ & Bass, BL 2013, Annals of Surgery, vol 258, no. 1, pp. 169-177. DOI: 10.1097/SLA.0b013e318288e18e

Comparison of laparoendoscopic single site (LESS) and conventional laparoscopic donor nephrectomy at a single institution
Stamatakis, L, Mercado, MA, Choi, JM, Sanchez, EJ, Gaber, AO, Knight, RJ, Mayer, WA & Link, RE 2013, BJU International, vol 112, no. 2, pp. 198-206. DOI: 10.1111/j.1464-410X.2012.11763.x

Outcomes of living donor renal transplants with a negative cross-match and pretransplant donor-specific antibody
Knight, RJ, Devos, JM, Patel, SJ, Land, G, Moore, LW, Gaber, L & Gaber, AO 2013, Transplantation Proceedings, vol 45, no. 4, pp. 1399-1401. DOI: 10.1016/j.transproceed.2013.01.027